MyFinsight
Home
Blog
About
Contact
mrna: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$716M
(-13.00%↓ Y/Y)
Inventory
$332M
(-19.42%↓ Y/Y)
Accounts receivable, net
$1,046M
(-33.12%↓ Y/Y)
Investments
$3,372M
(-35.44%↓ Y/Y)
Cash and cash
equivalents
$1,132M
(-31.14%↓ Y/Y)
Other non-current
assets
$530M
(-4.68%↓ Y/Y)
Right-of-use assets,
operating leases
$738M
(-5.87%↓ Y/Y)
Property, plant and
equipment, net
$2,126M
(-10.71%↓ Y/Y)
Investments, non-current
$2,143M
(-8.22%↓ Y/Y)
Total current assets
$6,598M
(-31.74%↓ Y/Y)
Total assets
$12,135M
(-23.21%↓ Y/Y)
Total liabilities and
stockholders equity
$12,135M
(-23.21%↓ Y/Y)
Total stockholders
equity
$9,330M
(-21.77%↓ Y/Y)
Total liabilities
$2,805M
(-27.63%↓ Y/Y)
Retained earnings
$8,049M
(-27.91%↓ Y/Y)
Accumulated other
comprehensive income (loss)
$27M
(145.45%↑ Y/Y)
Additional paid-in capital
$1,254M
(66.98%↑ Y/Y)
Other non-current
liabilities
$281M
(1.81%↑ Y/Y)
Financing lease
liabilities, non-current
$26M
(-95.84%↓ Y/Y)
Operating lease
liabilities, non-current
$660M
(-2.80%↓ Y/Y)
Deferred revenue,
non-current
$157M
(65.26%↑ Y/Y)
Total current
liabilities
$1,681M
(-23.63%↓ Y/Y)
Other current
liabilities
$73M
(5.80%↑ Y/Y)
Deferred revenue
$163M
(-56.99%↓ Y/Y)
Accrued liabilities
$1,178M
(-14.39%↓ Y/Y)
Accounts payable
$267M
(-28.42%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)